Bevazza 100mg Bevacizumab Injection

Bevazza 100mg Bevacizumab Injection is a targeted anti-cancer medication used in the treatment of various types of cancer, including colorectal cancer, lung cancer, kidney cancer, ovarian cancer, and cervical cancer. It contains Bevacizumab, a monoclonal antibody that works by blocking the formation of new blood vessels that tumors need to grow and spread. Administered intravenously under the supervision of a healthcare professional, Bevazza 100mg Injection is often used in combination with chemotherapy to improve treatment outcomes. Regular monitoring is important during treatment, as side effects such as high blood pressure, fatigue, bleeding, or delayed wound healing may occur. Patients should follow their oncologist’s guidance closely to ensure the safe and effective use of Bevazza 100mg Bevacizumab Injection.